SCHEDULE 13G/A
SCHEDULE 13G/ASchedule 13G ownership disclosure
Aura Biosciences Inc
Common Stock, $0.00001 par value per share · CUSIP: 05153U107
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 4,032,060.00 · Class: 6.3%
- FHMLSP, L.P.
Shares: 4,032,060.00 · Class: 6.3%
- FHMLSP, L.L.C.
Shares: 4,032,060.00 · Class: 6.3%
- Frazier Life Sciences X, L.P.
Shares: 128,520.00 · Class: 0.2%
- FHMLS X, L.P.
Shares: 128,520.00 · Class: 0.2%
- FHMLS X, L.L.C.
Shares: 128,520.00 · Class: 0.2%
- Frazier Life Sciences XI, L.P.
Shares: 342,210.00 · Class: 0.5%
- FHMLS XI, L.P.
Shares: 342,210.00 · Class: 0.5%
- FHMLS XI, L.L.C.
Shares: 342,210.00 · Class: 0.5%
- Frazier Life Sciences XII, L.P.
Shares: 597,210.00 · Class: 0.9%
- FHMLS XII, L.P.
Shares: 597,210.00 · Class: 0.9%
- FHMLS XII, L.L.C.
Shares: 597,210.00 · Class: 0.9%
- James N. Topper
Shares: 128,520.00 · Class: 0.2%
- Patrick J. Heron
Shares: 128,520.00 · Class: 0.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001231919-26-000155
- Form type
- SCHEDULE 13G/A
- Filer
- Aura Biosciences, Inc.
- CIK
- CIK 1501796
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership